Aliquots - Research Briefs

November 22, 2013

What makes us human?

Using computational tools to search for the genetic basis of what makes us human, Vanderbilt Assistant Professor of Biomedical Informatics Tony Capra and colleagues at the University of California-San Francisco have identified promising candidate regions.

By Leigh MacMillan
November 21, 2013

Therapeutic target for synovial sarcoma

Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer.

By Leigh MacMillan
November 13, 2013

Molecular circuits in ovarian cancer

Vanderbilt researchers have used bioinformatics analysis of gene expression data to describe molecular “circuits” that drive ovarian cancer.

By Leigh MacMillan
November 11, 2013

Amish aid study of Parkinson genetics

Amish populations are valuable for genetic research because of their isolation, shared ancestry and homogeneous lifestyles.

By Leigh MacMillan
November 8, 2013

Defusing ‘C. diff’ infection

By Leigh MacMillan
November 7, 2013

Neurotransmitter’s role in bone balance

Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling.

By Leigh MacMillan
October 30, 2013

Preserving antibiotic arsenal for TB

Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.
By Leigh MacMillan
October 28, 2013

Tool predicts risk for developmental delays in early childhood

A non-invasive measure of electrical brain activity in preterm infants predicts cognitive and communication functioning during early childhood, according to a new Vanderbilt University study.
By Leigh MacMillan
October 25, 2013

Targets of SIN drive cell division

Vanderbilt researchers have identified a key regulator of cell division.
By Leigh MacMillan
October 24, 2013

Shining a light on night blindness

Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness.
By VUMC News and Communications
October 16, 2013

Relaxin combats insulin resistance

The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance.
By Leigh MacMillan
October 14, 2013

Magnesium impacts vitamin D status

Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer.
By VUMC News and Communications
October 11, 2013

New target for stopping inflammation

Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases.
By Bill Snyder